Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Targeting specific T cells may help treat alopecia areata.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

More research is needed to understand and manage rheumatoid arthritis better.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

Researchers found genes and microRNAs that control curly fleece in Chinese Tan sheep.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

A gene mutation causes lanceolate hair in rats by disrupting hair shaft integrity.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Targeting ornithine decarboxylase can help prevent skin cancer.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Higher IL-21 levels may help predict alopecia areata activity.